Potent influenza neuraminidase inhibitors containing a novel ring structure.

被引：0
|
作者：
Babu, YS [1 ]
机构：
[1] BIOCRYST PHARMACEUT INC,BIRMINGHAM,AL 35244
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 214卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：136 / MEDI
页数：1
相关论文
共 50 条
  • [21] Neuraminidase Inhibitors and Influenza Infection
    Osthoff, Michael
    Erb, Stefan
    JAMA INTERNAL MEDICINE, 2016, 176 (03) : 415 - 415
  • [22] Influenza A, pregnancy and neuraminidase inhibitors
    Montane, Eva
    Lecumberri, Josep
    Luisa Pedro-Botet, Maria
    MEDICINA CLINICA, 2011, 136 (15): : 688 - 693
  • [23] Neuraminidase inhibitors in the therapy of influenza
    Fladerer, P
    Wenisch, C
    ACTA MEDICA AUSTRIACA, 2000, 27 (05) : 133 - 140
  • [24] Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors
    Mitrasinovic, Petar M.
    CURRENT DRUG TARGETS, 2010, 11 (03) : 315 - 326
  • [25] Prescription of neuraminidase inhibitors for influenza
    Madeley, D
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (04) : 207 - 208
  • [26] Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors
    Williams, MA
    Lew, W
    Mendel, DB
    Tai, CY
    Escarpe, PA
    Laver, WG
    Stevens, RC
    Kim, CU
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1837 - 1842
  • [27] Treatment of influenza with neuraminidase inhibitors
    Beard, Kate R.
    Brendish, Nathan J.
    Clark, Tristan W.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (06) : 514 - 519
  • [28] Influenza virus neuraminidase inhibitors
    Gubareva, LV
    Kaiser, L
    Hayden, FG
    LANCET, 2000, 355 (9206): : 827 - 835
  • [29] Neuraminidase inhibitors for influenza complications
    Del Mar, Chris
    Doshi, Peter
    Hama, Rokuro
    Jones, Mark
    Jefferson, Tom
    Heneghan, Carl
    Onakpoya, Igho
    Howick, Jeremy
    LANCET, 2014, 384 (9950): : 1260 - 1261
  • [30] Safety of neuraminidase inhibitors for influenza
    Jones, Mark
    Del Mar, Chis
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (05) : 603 - 608
12345